Clarity Updates
Announcement | September, 9th 2025
The data, presented at the Alzheimer’s Association International Conference (AAIC) on July 30th, 2025, demonstrate that delivering synchronized light and sound stimulation via Virtual Reality (VR) technology is safe, well-tolerated, and associated with acute memory improvements in this patient population.
Scientific Publication | September, 2nd 2025
The clinical study described in the paper evaluated Clarity’s proprietary VR-based 40 Hz gamma sensory stimulation platform in healthy older adults, marking the first time this approach has been tested in this population within a controlled trial.
Press | March, 27th 2025
“Clarity uses light and sound at gamma frequencies to induce a neuroprotective effect against Alzheimer's disease.”
- Keep reading -
Announcement | January, 24th 2025
Clarity's groundbreaking approach is the first to deliver 40Hz gamma-frequency light and sound stimulation via virtual reality (VR) technology to address key pathophysiological markers of Alzheimer’s disease (AD), including neuroinflammation and synaptic dysfunction. These results set the stage for a new category of non-invasive, disease-modifying therapies.